Pulsenmore Ltd. Ordinary Shares (PLSM) - Net Assets

Latest as of December 2025: $83.09 Million USD

Based on the latest financial reports, Pulsenmore Ltd. Ordinary Shares (PLSM) has net assets worth $83.09 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($101.85 Million) and total liabilities ($18.76 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Pulsenmore Ltd. Ordinary Shares asset portfolio for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets $83.09 Million
% of Total Assets 81.58%
Annual Growth Rate 66.1%
5-Year Change -47.83%
10-Year Change N/A
Growth Volatility 1089.53

Pulsenmore Ltd. Ordinary Shares - Net Assets Trend (2019–2025)

This chart illustrates how Pulsenmore Ltd. Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Check Pulsenmore Ltd. Ordinary Shares (PLSM) tangible net worth to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Pulsenmore Ltd. Ordinary Shares (2019–2025)

The table below shows the annual net assets of Pulsenmore Ltd. Ordinary Shares from 2019 to 2025. For live valuation and market cap data, see how much is Pulsenmore Ltd. Ordinary Shares worth.

Year Net Assets Change
2025-12-31 $83.09 Million -19.45%
2024-12-31 $103.15 Million -21.08%
2023-12-31 $130.70 Million -28.45%
2022-12-31 $182.67 Million +14.69%
2021-12-31 $159.28 Million +2918.76%
2020-12-31 $5.28 Million +33.44%
2019-12-31 $3.95 Million --

Equity Component Analysis

This analysis shows how different components contribute to Pulsenmore Ltd. Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 17205940900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock $2.00K 0.00%
Other Comprehensive Income $10.09 Million 12.15%
Other Components $256.14 Million 308.26%
Total Equity $83.09 Million 100.00%

Pulsenmore Ltd. Ordinary Shares Competitors by Market Cap

The table below lists competitors of Pulsenmore Ltd. Ordinary Shares ranked by their market capitalization.

Company Market Cap
Jiyuan Packaging Holdings Ltd
TW:8488
$23.74 Million
ChemX Materials Ltd
AU:CMX
$23.74 Million
TPC CONSOLIDATED LTD.
F:T7P
$23.74 Million
Higher Way Electronic Co Ltd
TWO:3268
$23.74 Million
Hove AS
CO:HOVE
$23.73 Million
Excel Force MSC Bhd
KLSE:0065
$23.73 Million
TVI Pacific Inc
V:TVI
$23.72 Million
Altech Chemicals Ltd
F:A3Y
$23.71 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Pulsenmore Ltd. Ordinary Shares's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 96,667,601 to 83,090,000, a change of -13,577,601 (-14.0%).
  • Net loss of 15,853,000 reduced equity.
  • New share issuances of 25,000 increased equity.
  • Other comprehensive income decreased equity by 851,161.
  • Other factors increased equity by 3,101,560.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-15.85 Million -19.08%
Share Issuances $25.00K +0.03%
Other Comprehensive Income $-851.16K -1.02%
Other Changes $3.10 Million +3.73%
Total Change $- -14.05%

Book Value vs Market Value Analysis

This analysis compares Pulsenmore Ltd. Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.28x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 5.69x to 0.28x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 $0.64 $3.65 x
2020-12-31 $0.47 $3.65 x
2021-12-31 $29.96 $3.65 x
2022-12-31 $30.44 $3.65 x
2023-12-31 $20.47 $3.65 x
2024-12-31 $15.09 $3.65 x
2025-12-31 $12.92 $3.65 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Pulsenmore Ltd. Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -19.08%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -39.61%
  • • Asset Turnover: 0.39x
  • • Equity Multiplier: 1.23x
  • Recent ROE (-19.08%) is above the historical average (-103.15%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 -117.29% 0.00% 0.00x 1.60x $-5.03 Million
2020 -475.00% 0.00% 0.00x 3.12x $-14.03 Million
2021 -16.67% -1623.89% 0.01x 1.09x $-40.97 Million
2022 -11.80% -204.54% 0.05x 1.26x $-40.03 Million
2023 -44.29% -946.46% 0.03x 1.36x $-71.18 Million
2024 -37.92% -380.25% 0.07x 1.46x $-46.32 Million
2025 -19.08% -39.61% 0.39x 1.23x $-24.16 Million

Industry Comparison

This section compares Pulsenmore Ltd. Ordinary Shares's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $411,255,254
  • Average return on equity (ROE) among peers: -85.10%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Pulsenmore Ltd. Ordinary Shares (PLSM) $83.09 Million -117.29% 0.23x $23.74 Million
Abbott Laboratories (ABT) $3.67 Billion 38.07% 1.09x $183.80 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM) $-72.62 Million 0.00% 0.00x $8.40 Million
Aethlon Medical Inc (AEMD) $1.50 Million -324.29% 0.70x $867.97K
Acutus Medical Inc (AFIB) $126.58 Million -80.56% 0.52x $903.35K
Adapthealth Corp (AHCO) $280.85 Million -57.55% 5.46x $1.39 Billion
20/20 Biolabs, Inc. Common Stock (AIDX) $2.15 Million -112.84% 0.45x $4.45 Million
Allurion Technologies, Inc. (ALUR) $-34.28 Million 0.00% 0.00x $13.77 Million
Autonomix Medical, Inc. Common Stock (AMIX) $5.89 Million -283.55% 0.29x $1.87 Million
Artivion Inc (AORT) $121.54 Million 6.06% 0.22x $1.16 Billion
Apyx Medical Inc (APYX) $6.01 Million -36.31% 0.22x $171.68 Million

About Pulsenmore Ltd. Ordinary Shares

NASDAQ:PLSM USA Medical Devices
Market Cap
$23.74 Million
Market Cap Rank
#24487 Global
#5180 in USA
Share Price
$3.65
Change (1 day)
+4.89%
52-Week Range
$3.28 - $6.59
All Time High
$6.59
About

Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.